Guj. Themis Bio.

42
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
309.60
-1.8 (-0.58%)
BSENSE

Jan 29

BSE+NSE Vol: 1.99 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -11.20% vs 14.45% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -11.60% vs 6.93% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 58.81% vs 30.08% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -17.56% vs 2.06% in Mar 2024

Compare Profit and Loss Results of Guj. Themis Bio.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
150.00
653.00
-503.00
-77.03%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
150.00
653.00
-503.00
-77.03%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
8.00
-9.00
-112.50%
Raw Materials Consumed
25.00
205.00
-180.00
-87.80%
Power & Fuel Cost
26.00
17.00
9.00
52.94%
Employee Cost
11.00
126.00
-115.00
-91.27%
Operating Expenses
8.00
29.00
-21.00
-72.41%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
35.00
-35.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
12.00
-8.00
-66.67%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
81.00
492.00
-411.00
-83.54%
Operating Profit (PBDIT) excl Other Income
69.00
160.00
-91.00
-56.88%
Other Income
1.00
12.00
-11.00
-91.67%
Operating Profit (PBDIT)
71.00
173.00
-102.00
-58.96%
Interest
0.00
1.00
-1.00
-100.00%
Profit before Depriciation and Tax
70.00
171.00
-101.00
-59.06%
Depreciation
5.00
21.00
-16.00
-76.19%
Profit Before Taxation & Exceptional Items
65.00
150.00
-85.00
-56.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
65.00
232.00
-167.00
-71.98%
Provision for Tax
16.00
49.00
-33.00
-67.35%
Profit After Tax
48.00
183.00
-135.00
-73.77%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
191.00
318.00
-127.00
-39.94%
Profit Available for appropriations
240.00
501.00
-261.00
-52.10%
Appropriations
240.00
501.00
-261.00
-52.10%
Equity Dividend (%)
67%
300%
-233.00
Earnings Per Share
4.48
110.8
-106.32
-95.96%
Profit And Loss - Net Sales
Net Sales 150.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.20% vs 14.45% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 69.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.60% vs 6.93% in Mar 2024

Profit And Loss - Interest
Interest 0.36 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 58.81% vs 30.08% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 48.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -17.56% vs 2.06% in Mar 2024